Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Didier Pomeranc has worked on the following 46 EPO patent applications which have been published in the last five years:

EP12700504

NOVEL TETRAHYDROQUINOLINE DERIVATIVES

IPC classification:
A61K 31/47, A61K 31/4709, A61K 31/496, A61K 31/5377, A61P 3/04, A61P 3/10, C07D 215/48, C07D 401/04, C07D 401/10, C07D 413/10, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13161113

Ibandronate polymorph B

IPC classification:
A61P 35/00, C07F 9/38
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12725834

PYRIDIN- 2 -AMIDES USEFUL AS CB2 AGONISTS

IPC classification:
A61K 31/44, A61P 29/00, C07D 213/81, C07D 401/04, C07D 401/14, C07D 405/04, C07D 405/12, C07D 405/14, C07D 409/12, C07D 409/14, C07D 413/12, C07D 413/14, C07D 417/06, C07D 417/12, C07D 491/107
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13161008

Ibandronate polymorph A

IPC classification:
A61P 35/00, C07F 9/38
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12778342

NOVEL PYRAZINE DERIVATIVES

IPC classification:
A61K 31/497, A61P 9/00, C07D 241/12, C07D 241/18, C07D 401/12, C07D 403/04, C07D 405/12, C07D 409/14, C07D 413/12, C07D 413/14, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12780208

[1, 2, 3]TRIAZOLO [4, 5 -D]PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2

IPC classification:
A61K 31/519, A61P 3/10, A61P 9/10, A61P 27/06, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12794684

[1, 2, 3]TRIAZOLO [4, 5 -D]PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2 AGONISTS

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12788530

NOVEL PYRROLIDINE DERIVATIVES AS INHIBITORS OF CATHEPSIN

IPC classification:
A61K 31/401, A61K 31/4025, A61K 31/4155, A61K 31/423, A61K 31/4439, A61K 31/5377, A61P 3/10, A61P 9/00, A61P 27/00, A61P 35/00, C07D 207/16, C07D 401/08, C07D 403/04, C07D 405/12, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13700506

MACROCYCLIC AMIDES AS PROTEASE INHIBITORS

IPC classification:
A61K 31/395, A61K 31/397, A61K 31/407, A61K 31/4353, A61P 3/10, C07D 273/01, C07D 498/08, C07D 498/18, C07D 498/22, C07D 515/08, C07D 515/22
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13702070

NOVEL AZETIDINE DERIVATIVES

IPC classification:
A61K 31/4439, A61P 3/00, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13703826

NOVEL PYRROLIDINE DERIVATIVES

IPC classification:
A61K 31/401, A61P 3/00, C07D 401/14, C07D 403/06, C07D 405/14, C07D 409/14, C07D 417/08, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13732543

NOVEL ADAMANTYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS

IPC classification:
A61K 31/403, A61K 31/47, A61P 29/00, C07D 209/08, C07D 209/44, C07D 215/08, C07D 215/14, C07D 215/233, C07D 215/50, C07D 215/54, C07D 217/06, C07D 241/42, C07D 265/36, C07D 271/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13750339

NOVEL PYRIDINE DERIVATIVES

IPC classification:
A61K 31/4439, A61K 31/444, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13759215

SOLID FORMS OF (S)-2-METHOXY-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-BENZO[B]THIOPHEN-7-YL}-PROPIONIC ACID AND OF SALTS THEREOF

IPC classification:
A61K 31/421, C07D 263/22
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13773658

SUBSTITUTED SULFONAMIDE COMPOUNDS

IPC classification:
A61K 31/18, A61K 31/337, A61K 31/415, A61K 31/44, A61K 31/444, A61K 31/50, A61K 31/501, A61K 31/505, A61K 31/506, C07C 305/06, C07C 311/18, C07D 231/18, C07D 401/04, C07D 401/12, C07D 403/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13774419

SUBSTITUTED PHENYLCARBAMATE COMPOUNDS

IPC classification:
A61K 31/495, A61K 31/5375, C07D 241/04, C07D 265/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13791771

[3-HETEROARYL-2-TRIFLUOROMETHYL-PROPYL]-PIPERIDIN-1-YLE OR -MORPHOLIN-4-YLE COMPOUNDS AS TRPA1 ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY DISEASES

IPC classification:
A61K 31/4184, A61K 31/422, A61K 31/4245, A61K 31/5377, A61P 11/00, C07D 403/06, C07D 413/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13791779

IMIDAZOPYRIDINE DERIVATIVES

IPC classification:
A61K 31/437, A61P 11/00, A61P 11/06, A61P 11/08, A61P 11/10, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13789018

NOVEL ACETAMIDE DERIVATIVES AS TRP CHANNEL ANTAGONISTS

IPC classification:
A61K 31/402, A61K 31/451, A61K 31/5377, A61P 11/00, C07D 207/16, C07D 211/34, C07D 265/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13798352

SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1)

IPC classification:
A61K 31/42, A61K 31/4439, A61P 35/00, C07D 261/18, C07D 413/04, C07D 413/10, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799270

SUBSTITUTED ISOXAZOLE AMINE COMPOUNDS AS INHIBITORS OF SCD1

IPC classification:
A61K 31/415, A61K 31/4155, A61P 35/00, C07D 261/14, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13799544

PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS

IPC classification:
C07D 213/81, C07D 401/04, C07D 401/06, C07D 401/14, C07D 405/12, C07D 405/14, C07D 413/06, C07D 413/14, C07D 417/06, C07D 471/10, C07D 487/08, C07D 491/04, C07D 491/08, C07D 491/10, C07D 495/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13799520

NOVEL PYRIDINE DERIVATIVES

IPC classification:
A61K 31/44, A61K 31/4427, A61P 3/10, A61P 9/00, A61P 27/02, A61P 29/00, C07D 213/81, C07D 401/04, C07D 401/12, C07D 401/14, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13799543

PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS

IPC classification:
A61K 31/444, A61P 29/00, C07D 213/81, C07D 401/06, C07D 401/12, C07D 405/04, C07D 409/12, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14, C07D 491/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13799545

NOVEL PYRAZINE DERIVATIVES AS CB2 RECEPTOR AGONISTS

IPC classification:
A61K 31/4965, A61K 31/497, A61P 9/00, A61P 27/00, A61P 29/00, C07D 401/14, C07D 403/04, C07D 403/06, C07D 403/14, C07D 413/06, C07D 413/14, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14709590

NOVEL PYRAZOL DERIVATIVES

IPC classification:
C07D 471/04, C07D 473/04, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14797295

INHIBITORS OF THE KYNURENINE PATHWAY

IPC classification:
C07D 307/82
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14712287

NOVEL PYRIDINE DERIVATIVES

IPC classification:
A61K 31/422, A61K 31/4245, C07D 403/04, C07D 413/04, C07D 413/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14720136

PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR AGONISTS

IPC classification:
A61K 31/519, A61P 1/00, A61P 3/00, A61P 9/00, A61P 25/00, A61P 29/00, C07D 487/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14719767

PURINE DERIVATIVES AS CB2 RECEPTOR AGONISTS

IPC classification:
A61K 31/52, A61P 1/00, A61P 3/00, A61P 9/00, A61P 25/00, A61P 29/00, C07D 473/16, C07D 473/18, C07D 473/34, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14730804

NOVEL TETRAZOLONE DERIVATIVES

IPC classification:
A61K 31/41, A61K 31/4439, A61K 31/454, A61P 25/00, C07D 257/04, C07D 401/04, C07D 401/06, C07D 401/12, C07D 403/04, C07D 403/06, C07D 403/12, C07D 403/14, C07D 413/06, C07D 413/14, C07D 491/107
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14761320

NOVEL TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11774017

TETRAHYDROQUINOLINE DERIVATIVES USED AS AMPK ACTIVATORS

IPC classification:
A61K 31/47, A61P 3/02, A61P 3/06, A61P 3/10, A61P 35/00, C07D 215/12, C07D 215/18, C07D 215/48, C07D 401/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14781878

THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY

IPC classification:
A61K 31/519, A61P 25/00, C07D 513/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14789194

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

IPC classification:
A61K 31/4025, A61P 29/00, C07D 207/48, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 417/12, C07D 451/02, C07D 491/048
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11776459

PYRROLIDINE DERIVATIVES USED AS CATHEPSIN INHIBITORS

IPC classification:
A61K 31/44, A61K 31/506, A61P 3/10, A61P 9/00, A61P 35/00, C07D 401/04, C07D 403/04, C07D 413/04, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11730935

NOVEL TETRAHYDROQUINOLINE DERIVATIVES

IPC classification:
A61K 31/4375, A61K 31/47, A61K 31/4709, A61P 3/04, A61P 3/06, A61P 3/10, A61P 35/00, C07D 215/48, C07D 401/06, C07D 405/12, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11715896

NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES

IPC classification:
A61K 31/47, A61P 3/00, C07D 215/12, C07D 215/18, C07D 215/36, C07D 215/48, C07D 401/04, C07D 401/10, C07D 401/12, C07D 405/12, C07D 413/10, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10790751

SPIRO INDOLE-CYCLOPROPANE INDOLINONES USEFUL AS AMPK MODULATORS

IPC classification:
A61K 31/404, A61K 31/4406, A61P 3/04, A61P 3/10, C07D 209/34, C07D 401/08, C07D 401/12, C07D 403/04, C07D 403/10, C07D 413/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16165017

PYRIDIN-2-AMIDES USEFUL AS CB2 AGONISTS

IPC classification:
A61K 31/44, A61P 29/00, C07D 213/81, C07D 401/04, C07D 401/14, C07D 405/04, C07D 405/12, C07D 405/14, C07D 409/12, C07D 409/14, C07D 413/12, C07D 413/14, C07D 417/06, C07D 417/12, C07D 491/107
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15712968

5,6-DISUBSTITUTED PYRIDINE-2-CARBOXAMIDES AS CANNABINOID RECEPTOR AGONISTS

IPC classification:
A61K 31/4439, A61P 29/00, C07D 213/81, C07D 401/04, C07D 401/14, C07D 405/14, C07D 413/12, C07D 413/14, C07D 417/06, C07D 417/12, C07D 491/10
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15713492

PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS

IPC classification:
A61K 31/4427, A61K 31/455, A61K 31/497, A61P 25/00, C07D 401/04, C07D 401/12, C07D 413/12, C07D 413/14, C07D 417/06
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15756368

CRYSTALLINE FORMS OF AN ESTROGEN RECEPTOR MODULATOR

IPC classification:
A61K 31/416, A61P 35/00, C07D 231/56
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15784679

RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND

IPC classification:
A61K 51/04, C07B 59/00, C07D 231/40, G01N 33/534
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Applicant:
University of Zurich (Universität Zürich)
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15788083

TRIAZOLO[4,5-D]PYRIMIDINES AS AGONISTS OF THE CANNABINOID RECEPTOR 2

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15801459

NOVEL PIPERIDINE DERIVATIVES

IPC classification:
A61K 31/445, A61P 5/00, C07D 403/14, C07D 413/14, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Didier Pomeranc, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature